Saito H, Yamaoka Y, Ishizone S, Maruta F, Sugiyama A, Graham D Y, Yamauchi K, Ota H, Miyagawa S
Department of Surgery, Shinshu University School of Medicine, Matsumoto, Nagano, Japan.
Gut. 2005 May;54(5):584-90. doi: 10.1136/gut.2004.058982.
The roles of the virD4 and the cagG genes in the cag pathogenicity island of Helicobacter pylori for gastroduodenal pathogenesis are unclear and their roles in vivo have not been examined.
Seven week old male Mongolian gerbils were inoculated with the wild type H pylori TN2GF4, its isogenic virD4, or cagG mutants. Animals were sacrificed at 4, 12, and 24 weeks after inoculation. Gastric inflammation and H pylori density were evaluated by histology, inflammatory response (as measured by interleukin (IL)-1beta mRNA levels), proliferative activity (as assessed by 5'-bromo-2'deoxyuridine labelling indices), and host systemic reaction (as measured by anti-H pylori IgG antibody).
Degree of gastric inflammation, proliferative activity, and mucosal IL-1beta mRNA levels remained low throughout the first 12 weeks in gerbils infected with the virD4 mutants. Degree of gastric inflammation and proliferative activity increased at 24 weeks with the virD4 mutants reaching levels comparative with those seen at four weeks with the wild-type strains. Mucosal IL-1beta mRNA levels were also increased at 24 weeks with the virD4 mutants and levels at 24 weeks were similar between the wild-type and virD4 mutants. In contrast, gerbils infected with the cagG mutants had reduced ability to colonise gerbils, and no or little gastric inflammation or proliferative activity was observed.
Loss of the virD4 gene temporally retarded but did not abrogate gastric inflammation. Loss of the cagG gene abolished gastric inflammation partially via reduced ability to colonise gerbils. Unknown factors related to the type IV secretion system other than CagA may influence gastric inflammation.
幽门螺杆菌cag致病岛中的virD4和cagG基因在胃十二指肠发病机制中的作用尚不清楚,且其在体内的作用尚未得到研究。
将7周龄雄性蒙古沙鼠接种野生型幽门螺杆菌TN2GF4、其同基因的virD4或cagG突变体。在接种后4周、12周和24周处死动物。通过组织学、炎症反应(通过白细胞介素(IL)-1β mRNA水平测量)、增殖活性(通过5'-溴-2'-脱氧尿苷标记指数评估)和宿主全身反应(通过抗幽门螺杆菌IgG抗体测量)来评估胃炎症和幽门螺杆菌密度。
在感染virD4突变体的沙鼠中,在最初的12周内,胃炎症程度、增殖活性和黏膜IL-1β mRNA水平一直较低。在24周时,virD4突变体的胃炎症程度和增殖活性增加,达到与野生型菌株在4周时所见水平相当。在24周时,virD4突变体的黏膜IL-1β mRNA水平也增加,且野生型和virD4突变体在24周时的水平相似。相比之下,感染cagG突变体的沙鼠定殖能力降低,未观察到或仅观察到极少的胃炎症或增殖活性。
virD4基因的缺失暂时延缓但并未消除胃炎症。cagG基因的缺失通过降低定殖沙鼠的能力部分消除了胃炎症。除CagA外,与IV型分泌系统相关的未知因素可能影响胃炎症。